Richard Bernstein Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45M | Sell |
7,751
-855
| -10% | -$381K | 0.09% | 118 |
|
|
2025
Q1 | $4.17M | Sell |
8,606
-444
| -5% | -$215K | 0.1% | 92 |
|
|
2024
Q4 | $3.64M | Hold |
9,050
| – | – | 0.08% | 129 |
|
|
2024
Q3 | $4.21M | Hold |
9,050
| – | – | 0.09% | 100 |
|
|
2024
Q2 | $4.24M | Buy |
9,050
+2
| +0% | +$937 | 0.09% | 79 |
|
|
2024
Q1 | $3.78M | Hold |
9,048
| – | – | 0.08% | 102 |
|
|
2023
Q4 | $3.68M | Sell |
9,048
-2,684
| -23% | -$1.09M | 0.08% | 86 |
|
|
2023
Q3 | $4.08M | Hold |
11,732
| – | – | 0.09% | 73 |
|
|
2023
Q2 | $4.13M | Sell |
11,732
-1,596
| -12% | -$562K | 0.09% | 72 |
|
|
2023
Q1 | $4.2M | Hold |
13,328
| – | – | 0.09% | 82 |
|
|
2022
Q4 | $3.85M | Hold |
13,328
| – | – | 0.09% | 94 |
|
|
2022
Q3 | $3.86M | Hold |
13,328
| – | – | 0.1% | 98 |
|
|
2022
Q2 | $3.76M | Buy |
+13,328
| New | +$3.76M | 0.08% | 121 |
|
|
2020
Q2 | – | Sell |
-3,364
| Closed | -$800K | – | 276 |
|
|
2020
Q1 | $800K | Sell |
3,364
-11,286
| -77% | -$2.68M | 0.03% | 171 |
|
|
2019
Q4 | $3.21M | Hold |
14,650
| – | – | 0.1% | 148 |
|
|
2019
Q3 | $2.48M | Sell |
14,650
-5,958
| -29% | -$1.01M | 0.08% | 171 |
|
|
2019
Q2 | $3.78M | Hold |
20,608
| – | – | 0.13% | 127 |
|
|
2019
Q1 | $3.79M | Hold |
20,608
| – | – | 0.12% | 139 |
|
|
2018
Q4 | $3.42M | Hold |
20,608
| – | – | 0.13% | 158 |
|
|
2018
Q3 | $3.97M | Buy |
+20,608
| New | +$3.97M | 0.11% | 193 |
|